Ginkgo Bioworks Holdings Inc. 已正式披露其2025年第四季度及全年的财务业绩。公司同时宣布了重要的战略调整:未来将集中资源发展自主实验室解决方案,并计划剥离其非核心的生物安全业务板块。这一举措标志着公司正进一步优化其业务组合,专注于具有更高增长潜力的核心领域。
Ginkgo Bioworks Holdings Inc. 已正式披露其2025年第四季度及全年的财务业绩。公司同时宣布了重要的战略调整:未来将集中资源发展自主实验室解决方案,并计划剥离其非核心的生物安全业务板块。这一举措标志着公司正进一步优化其业务组合,专注于具有更高增长潜力的核心领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.